SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC secures USFDA’s nod for Fluconazole Tablets

09 Jan 2026 Evaluate

FDC has received abbreviated new drug application (ANDA) approval from United States Food and Drug Administration (USFDA) for Fluconazole Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg.

Earlier, the company had secured ANDA approval from United States Food and Drug Administration (USFDA), for Pilocarpine Hydrochloride Ophthalmic Solution USP, 1%, 2%, and 4% (15 mL).

FDC is among India’s leading fully integrated pharmaceutical companies.

FDC Share Price

356.00 3.75 (1.06%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×